Drugs in R & D

, Volume 1, Issue 5, pp 371–373 | Cite as

GP IIb/IIIa Antagonists

Summary and Table
  • Stephen G. Coleman
  • Rosemary Duff
Section 1: GP IIb/IIIa Antagonist in Cardiology Adis Profile Summary


Acute Coronary Syndrome Abciximab Cerebral Malaria Eptifibatide Tirofiban 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Foster RH, Wiseman LR. Abciximab: an updated review of its use in ischaemic heart disease. Drugs 1998 Oct; 56 (4): 629–65PubMedCrossRefGoogle Scholar
  2. 2.
    McClellan KJ, Goa KL. Tirofiban: a review of its use in acute coronary syndromes. Drugs 1998 Dec; 56 (6): 1067–80PubMedCrossRefGoogle Scholar
  3. 3.
    Goa KL, Noble S. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs 1999 Mar; 57 (3): 439–62PubMedCrossRefGoogle Scholar
  4. 4.
    Dooley M, Goa KL. Lamifiban. Drugs 1999 Feb; 57 (2): 215–21PubMedCrossRefGoogle Scholar
  5. 5.
    Dooley M, Goa KL. Sibrafiban. Drugs 1999 Feb; 57 (2): 225–30PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1999

Authors and Affiliations

  • Stephen G. Coleman
    • 1
  • Rosemary Duff
    • 1
  1. 1.Adis International LtdAucklandNew Zealand

Personalised recommendations